Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 5, 2014, Pages 1142-1152.e5

  Campillo Gimenez, Laure ^a,b   Casulli, Sarah ^a,b   Dudoit, Yasmine ^a,c   Seang, Sophie ^a,c   Carcelain, Guislaine ^b,c   Lambert Niclot, Sidonie ^a,c   Appay, Victor ^b   Autran, Brigitte ^b,c   Tubiana, Roland ^a,c   Elbim, Carole ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

HIV; IL 17; IL 18; IL 22; inflammation; Neutrophils

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; C REACTIVE PROTEIN; CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; INTEGRASE INHIBITOR; INTERLEUKIN 17; INTERLEUKIN 22; L SELECTIN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ANTIRETROVIRUS AGENT; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE FUNCTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOPHENOTYPING; INFECTION CONTROL; INFLAMMATORY DISEASE; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; MONONUCLEAR PHAGOCYTE; NEUTROPHIL; NEUTROPHIL COUNT; NEUTROPHIL HYPERACTIVATION; PROTEIN EXPRESSION; RESPIRATORY BURST; RISK ASSESSMENT; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; VIRUS LOAD; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-17; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; NEUTROPHILS;

EID: 84914155258     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.05.040     Document Type: Article

References (56)

1. S.G. Deeks, and A.N. Phillips HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity BMJ 338 2009 a3172
2. G. D'Ettorre, M. Paiardini, G. Ceccarelli, G. Silvestri, and V. Vullo HIV-associated immune activation: from bench to bedside AIDS Res Hum Retroviruses 27 2011 355 364
3. N. Borregaard Neutrophils, from marrow to microbes Immunity 33 2010 657 670
4. M.L. Gabelloni, A.S. Trevani, J. Sabatté, and J. Geffner Mechanisms regulating neutrophil survival and cell death Semin Immunopathol 35 2013 423 437
5. A.C. Cave, A.C. Brewer, A. Narayanapanicker, R. Ray, D.J. Grieve, and S. Walker NADPH oxidases in cardiovascular health and disease Antioxid Redox Signal 8 2006 691 728
6. C.D. Garlichs, S. Eskafi, I. Cicha, A. Schmeisser, B. Walzog, and D. Raaz Delay of neutrophil apoptosis in acute coronary syndromes J Leukoc Biol 75 2004 828 835
7. A. Mirshafiey, and M. Mohsenzadegan The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis Iran J Allergy Asthma Immunol 7 2008 195 202
8. J. El-Benna, P.M.-C. Dang, and M.-A. Gougerot-Pocidalo Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane Semin Immunopathol 30 2008 279 289
9. C. Elbim, M. Prevot, F. Bouscarat, E. Franzini, S. Chollet-Martin, and J. Hakim Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming Blood 84 1994 2759 2766
10. C. Michailidis, G. Giannopoulos, V. Vigklis, K. Armenis, A. Tsakris, and P. Gargalianos Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy Clin Exp Immunol 167 2012 499 504
11. B. Heit, G. Jones, D. Knight, J.M. Antony, M.J. Gill, and C. Brown HIV and other lentiviral infections cause defects in neutrophil chemotaxis, recruitment, and cell structure: immunorestorative effects of granulocyte-macrophage colony-stimulating factor J Immunol 177 2006 6405 6414
12. S. François, J. El Benna, P.M.C. Dang, E. Pedruzzi, M.-A. Gougerot-Pocidalo, and C. Elbim Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad J Immunol 174 2005 3633 3642
13. I. Moldovan, J. Galon, I. Maridonneau-Parini, S. Roman Roman, C. Mathiot, and W.H. Fridman Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions Immunol Lett 68 1999 125 134
14. G.M. Venturi, L. Tu, T. Kadono, A.I. Khan, Y. Fujimoto, and P. Oshel Leukocyte migration is regulated by L-selectin endoproteolytic release Immunity 19 2003 713 724
15. H. Sengeløv, L. Kjeldsen, M.S. Diamond, T.A. Springer, and N. Borregaard Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils J Clin Invest 92 1993 1467 1476
16. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe, M. Dalod, V. Grau, and D.N. Hart Nomenclature of monocytes and dendritic cells in blood Blood 116 2010 e74 e80
17. A. De Baey, I. Mende, G. Baretton, A. Greiner, W.H. Hartl, and P.A. Baeuerle A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha J Immunol 170 2003 5089 5094
18. C.-A. Dutertre, S. Amraoui, A. DeRosa, J.-P. Jourdain, L. Vimeux, and M. Goguet Pivotal role of M-DC8+ monocytes from viremic HIV-infected patients in TNF overproduction in response to microbial products Blood 120 2012 2259 2268
19. A.M. Levine, R. Karim, W. Mack, D.J. Gravink, K. Anastos, and M. Young Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study Arch Intern Med 166 2006 405
20. L. Papagno, C.A. Spina, A. Marchant, M. Salio, N. Rufer, and S. Little Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection PLoS Biol 2 2004 E20
21. M.J. Vinikoor, A. Cope, C.L. Gay, G. Ferrari, K.S. McGee, and J.D. Kuruc Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation J Acquir Immune Defic Syndr 62 2013 505 508
22. S. Fernandez, M.A. French, and P. Price Immunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART Dis Markers 31 2011 337 342
23. G. Ricevuti Host tissue damage by phagocytes Ann N Y Acad Sci 832 1997 426 448
24. H. Garg, A. Joshi, and D. Mukherjee Cardiovascular complications of HIV infection and treatment Cardiovasc Hematol Agents Med Chem 11 2013 58 66
25. B.A.I. Payne, I.J. Wilson, C.A. Hateley, R. Horvath, M. Santibanez-Koref, and D.C. Samuels Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations Nat Genet 43 2011 806 810
26. C.D. Sadik, N.D. Kim, and A.D. Luster Neutrophils cascading their way to inflammation Trends Immunol 32 2011 452 460
27. S. Eyerich, K. Eyerich, A. Cavani, and C. Schmidt-Weber IL-17 and IL-22: siblings, not twins Trends Immunol 31 2010 354 361
28. Y. He, J. Li, Y. Zheng, Y. Luo, H. Zhou, and Y. Yao A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients AIDS Res Hum Retroviruses 28 2012 339 345
29. C.J. Kim, A. Nazli, O.L. Rojas, D. Chege, Z. Alidina, and S. Huibner A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis Mucosal Immunol 5 2012 670 680
30. P. Boros, E. Gardos, G.J. Bekesi, and J.C. Unkeless Change in expression of Fc gamma RIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals Clin Immunol Immunopathol 54 1990 281 289
31. D. Torre, L. Gennero, F. Baccino, F. Speranza, G. Biondi, and A. Pugliese Impaired macrophage phagocytosis of apoptotic neutrophils in patients with human immunodeficiency virus type 1 infection Clin Vaccine Immunol 9 2002 983
32. A. Cozzi-Lepri, M.A. French, J. Baxter, P. Okhuysen, M. Plana, and J. Neuhaus Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial AIDS 25 2011 1207 1217
33. M. Almeida, M. Cordero, J. Almeida, and A. Orfao Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients Cytometry B Clin Cytom 72 2007 22 33
34. A. Calmy, A. Gayet-Ageron, F. Montecucco, A. Nguyen, F. Mach, and F. Burger HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial AIDS 23 2009 929 939
35. J.V. Baker, J. Neuhaus, D. Duprez, L.H. Kuller, R. Tracy, and W.H. Belloso Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection J Acquir Immune Defic Syndr 56 2011 36 43
36. D.L. Regidor, R. Detels, E.C. Breen, D.P. Widney, L.P. Jacobson, and F. Palella Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation AIDS 25 2011 303 314
37. T.H. Burdo, M.R. Lentz, P. Autissier, A. Krishnan, E. Halpern, and S. Letendre Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy J Infect Dis 204 2011 154 163
38. N.T. Funderburg, D.A. Zidar, C. Shive, A. Lioi, J. Mudd, and L.W. Musselwhite Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome Blood 120 2012 4599 4608
39. C. Longenecker, N. Funderburg, Y. Jiang, S. Debanne, N. Storer, and D. Labbato Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals HIV Med 14 2013 385 390
40. F.L. Van de Veerdonk, M.G. Netea, C.A. Dinarello, and L.A.B. Joosten Inflammasome activation and IL-1β and IL-18 processing during infection Trends Immunol 32 2011 110 116
41. A. Iannello, M.-R. Boulassel, S. Samarani, C. Tremblay, E. Toma, and J.-P. Routy HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication J Infect Dis 201 2010 608 617
42. A. Pontillo, L.T. Silva, T.M. Oshiro, C. Finazzo, S. Crovella, and A.J.S. Duarte HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients AIDS 26 2012 11 18
43. T.W. Chun, L. Stuyver, S.B. Mizell, L.A. Ehler, J.A. Mican, and M. Baseler Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy Proc Natl Acad Sci U S A 94 1997 13193 13197
44. A. Cossarizza, M. Pinti, M. Nasi, L. Gibellini, S. Manzini, and E. Roat Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation Mitochondrion 11 2011 750 755
45. C. Elbim, C. Guichard, P.M.C. Dang, M. Fay, E. Pedruzzi, and H. Demur Interleukin-18 primes the oxidative burst of neutrophils in response to formyl-peptides: role of cytochrome b558 translocation and N-formyl peptide receptor endocytosis Clin Diagn Lab Immunol 12 2005 436 446
46. T.H. Wyman, C.A. Dinarello, A. Banerjee, F. Gamboni-Robertson, A.A. Hiester, and K.M. England Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation J Leukoc Biol 72 2002 401 409
47. C.F. Fortin, T. Ear, and P.P. McDonald Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils FASEB J 23 2009 194 203
48. L. Campillo-Gimenez, M.-C. Cumont, M. Fay, H. Kared, V. Monceaux, and O. Diop AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection J Immunol 184 2010 984 992
49. M. Gelderblom, A. Weymar, C. Bernreuther, J. Velden, P. Arunachalam, and K. Steinbach Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke Blood 120 2012 3793 3802
50. Z. Wang, J. Lee, Y. Zhang, H. Wang, X. Liu, and F. Shang Increased Th17 cells in coronary artery disease are associated with neutrophilic inflammation Scand Cardiovasc J 45 2011 54 61
51. L. Fontao, N.C. Brembilla, I. Masouyé, G. Kaya, C. Prins, and N. Dupin Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skin Br J Dermatol 166 2012 687 689
52. Y. Kobayashi The role of chemokines in neutrophil biology Front Biosci 13 2008 2400 2407
53. H.-L. Ma, S. Liang, J. Li, L. Napierata, T. Brown, and S. Benoit IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation J Clin Invest 118 2008 597 607
54. K. Sugimoto, A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, and A.K. Bhan IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis J Clin Invest 118 2008 534 544
55. L.A. Zenewicz, G.D. Yancopoulos, D.M. Valenzuela, A.J. Murphy, S. Stevens, and R.A. Flavell Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease Immunity 29 2008 947 957
56. G.F. Sonnenberg, L.A. Fouser, and D. Artis Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22 Nat Immunol 12 2011 383 390